How to escape the cancer attractor: Rationale and limitations of multi-target drugs
Author:
Funder
Alberta Innovates (iCore)
Institute for Systems Biology
Publisher
Elsevier BV
Subject
Cancer Research
Reference87 articles.
1. Acquired resistance to drugs targeting receptor tyrosine kinases;Rosenzweig;Biochem Pharmacol,2012
2. Promiscuous drugs compared to selective drugs (promiscuity can be a virtue);Mencher;BMC Clin Pharmacol,2005
3. Systems approaches to polypharmacology and drug discovery;Boran;Curr Opin Drug Discov Dev,2010
4. Analysis of the yield of phase II combination therapy trials in medical oncology;Maitland;Clin Cancer Res,2010
5. Can cell systems biology rescue drug discovery?;Butcher;Nat Rev Drug Discov,2005
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Search for System’s Parameters: Statistical and Dynamical Description from Complex Network Analysis;Methods in Molecular Biology;2023-12-08
2. Nonlinear control designs and their application to cancer differentiation therapy;Mathematical Biosciences;2023-12
3. Quantifying cancer cell plasticity with gene regulatory networks and single-cell dynamics;Frontiers in Network Physiology;2023-09-04
4. Theoretical investigation of the pathway-based network of type 2 diabetes mellitus-related genes;The European Physical Journal B;2023-06
5. Challenges and Perspectives in Target Identification and Mechanism Illustration for Chinese Medicine;Chinese Journal of Integrative Medicine;2023-02-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3